drugset / Trial / NCT00001428

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer

NCT00001428 ↗

Phase 2 Completed 65 enrolled National Cancer Institute (NCI)
Treatment

Summary

This protocol will evaluate the activity of 5-Fluorouracil (FUra) given as a 1 hour infusion in combination with leucovorin (LV) and interferon IFN alpha-2a in patients with advanced, measurable colorectal cancer.

Timeline

Start
1995-02
Primary completion
—
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule 425 mg/m2 Intravenous

Indications